期刊文献+

血清SCC与CysC在慢性肾脏病患者中的变化及临床价值 被引量:2

Change and clinical value of serum SCC and CysC in patients with chronic kidney disease
原文传递
导出
摘要 目的探讨血清鳞状细胞癌抗原(SCC)与胱抑素C(CysC)在慢性肾脏病(CKD)患者的变化及临床价值。方法选取110例CKD患者(研究组)及同期100例健康体检者(对照组)作为研究对象,按照肾小球滤过率将CKD患者分为CKD1期25例,CKD2期22例,CKD3期26例,CKD4期18例,CKD5期19例;检测各组研究对象的血清SCC,CysC、肌酐和尿微量白蛋白(mALB)水平,分析CKD患者血清SCC与CysC的变化及其相关性。结果研究组中患者血清SCC、CysC、肌酐及mALB水平显著高于对照组,差异均有统计学意义(P<0.05),并且CKD患者血清SCC、CysC、肌酐及mALB水平随着CKD分期的增加而明显升高,各分期间差异均具有统计学意义(P<0.05);血清SCC水平与CysC、肌酐及mALB均呈正相关(r=0.764,r=0.692,r=0.655,P<0.05)。结论 CKD患者血清SCC、CysC、肌酐及mALB水平均显著升高,并随着CKD分期的增加而增加,并且血清SCC与CysC、肌酐及mALB均成正相关,因此对CKD的诊断有重要的临床价值。 Objective To explore changes of serum squamous cell carcinoma antigen( SCC) and cystatin C( CysC)concentration of patients with chronic kidney disease( CKD) and their clinical value. Methods Totally 110 patients with CKD( research group) were selected and 100 cases of healthy physical examination( control group) as the research object,the CKD patients were divided into the stage 1 group( n = 25),stage 2 group( n = 22),stage 3 group( n = 26),stage 4 group( n = 18) and stage 5 group( n = 19) by GFR. The levels of serum SCC,CysC,createinine and the urine trace albumin( mALB) in the research group and control group were detected,the changes of serum SCC and CysC were analyzed and the correlation between them in CKD patients were analyzed. Results The levels of serum SCC,CysC,creatinine and mALB in the research group were significantly higher than those in the control group( P〈0. 05); The levels of serum SCC,CysC,creatinine and mALB for patients were significantly increased with the increase of CKD stage increased( P〈0. 05); the positive correlation were demonstrated among serum SCC and CysC,creatinine,mALB( r = 0. 764,r = 0. 692,r = 0. 655,P〈0. 05). Conclusions The levels of serum SCC,CysC,creatinine and mALB in CKD patients were increased significantly,which were significantly increased with the increase of CKD stage increased; And the levels of serum SCC,CysC,creatinine and mALB for patients were significantly increased with the increase of CKD stage increased,which the diagnosis of chronic kidney disease( CKD) has important clinical value.
作者 乔晓亮
出处 《医药论坛杂志》 2017年第10期31-33,共3页 Journal of Medical Forum
关键词 慢性肾脏病 鳞状细胞癌抗原 胱抑素C 肌酐 Chronic kidney disease Squamous cell carcinoma antigen Cystatin C Creatinine
  • 相关文献

参考文献10

二级参考文献92

  • 1曾显声,周燕斌.肺癌血清肿瘤标志物的研究现状[J].国际内科学杂志,2007,34(2):73-76. 被引量:51
  • 2赵欣,邵淑丽.鳞状上皮细胞癌抗原与宫颈鳞癌[J].国外医学(妇产科学分册),2007,34(1):60-62. 被引量:17
  • 3陈继红,高坤.孙伟以肾虚湿瘀立论揭示慢性肾脏病发病机制[J].辽宁中医杂志,2007,34(4):420-420. 被引量:44
  • 4塚本雄介,万毅刚.国际肾脏病指南——改善全球性肾脏病预后[J].日本医学介绍,2007,28(6):274-276. 被引量:10
  • 5Silverman G A, Bird P I, Carrell R W, et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature [ J ]. J Biol Chem, 2001,276 ( 36 ) : 33293 - 33296.
  • 6Masumoto K, Sakata Y, Arima K, et al. Inhibitory mechanism of a crossclass serpin the squamous cell carcinoma antigen 1 [ J ]. J Biol Chem ,2003,278 (46) :45296 - 45304.
  • 7Roszak A, Bratos K, Gomy A, et al. Evaluation of SCC antigen in patients with advanced cervix cancer treated with radiation[ J]. Ginekol Pol, 1996,67 ( 9 ) :457-459.
  • 8Duk J M, Groeneier K H, de - Bruijn H W, et al. Pretreat merit serum squamous cell carcinoma antigen a newly identified prognosis factor in early- stage cervical carcinoma[ J ]. Clin Oncol, 1996,14 (1) : 111-118.
  • 9Sakata Y,Arima K,Takai T,et al. The squamous cell carcinoma antigen 2 inhibits the cysteine proteinase activity of a major mite allergen,Derpl [J]. J Biol Chem,2004,279(7) :5081 - 5087.
  • 10Upham J, Campbell B. Utility of squamous cell carcinoma antigen ( SCCAg) as a tumor marker in pulmonary malignancy[ J]. Respir Med, 1992,86(3 ) :201-203.

共引文献83

同被引文献28

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部